About
Bob van de Loo is a Researcher at the Department of Pharmacy, Erasmus University Medical Center in Rotterdam, Netherlands. His work focuses on clinical pharmacology and pharmacoepidemiology, particularly in geriatric populations and infectious disease outcomes.
Research interests include:
- Pharmacotherapy effects in COVID-19 and SARS coronavirus
- Frailty and mortality risk assessment in elderly patients
- Clinical decision-making in triage scenarios
- Cohort studies on medication safety and outcomes
His recent publications (2020-2025) demonstrate a consistent focus on COVID-19 outcomes, frailty assessment, and pharmacological interventions. Research methodologies emphasize large-scale cohort studies and clinical trial protocols in collaboration with multidisciplinary teams like the COMET Research Group.
No scientific awards, grants, or student advising relationships are documented in available sources.
0Publications listed
Find Bob van de Loo elsewhere
Related Searches
You Might Also Like
- HHarmke BosErasmus University Rotterdam · Researcher
- BBruno StrickerErasmus University Rotterdam · Researcher
- MMerel van de LooErasmus University Rotterdam · Researcher
- LLoes VisserErasmus University Rotterdam · Associate Professor
- CC.M. (Lotte) FalkeUtrecht University · Assistant Professor
- MMelvin LafeberErasmus University Rotterdam · Researcher